165 related articles for article (PubMed ID: 28881734)
1. Targeting aldehyde dehydrogenase activity in head and neck squamous cell carcinoma with a novel small molecule inhibitor.
Kim J; Shin JH; Chen CH; Cruz L; Farnebo L; Yang J; Borges P; Kang G; Mochly-Rosen D; Sunwoo JB
Oncotarget; 2017 Aug; 8(32):52345-52356. PubMed ID: 28881734
[TBL] [Abstract][Full Text] [Related]
2. FGFR signaling regulates resistance of head and neck cancer stem cells to cisplatin.
McDermott SC; Rodriguez-Ramirez C; McDermott SP; Wicha MS; Nör JE
Oncotarget; 2018 May; 9(38):25148-25165. PubMed ID: 29861860
[TBL] [Abstract][Full Text] [Related]
3. Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells.
Okazaki S; Shintani S; Hirata Y; Suina K; Semba T; Yamasaki J; Umene K; Ishikawa M; Saya H; Nagano O
Oncotarget; 2018 Sep; 9(73):33832-33843. PubMed ID: 30333913
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenases and cell proliferation.
Muzio G; Maggiora M; Paiuzzi E; Oraldi M; Canuto RA
Free Radic Biol Med; 2012 Feb; 52(4):735-46. PubMed ID: 22206977
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
[TBL] [Abstract][Full Text] [Related]
6. Aldehyde dehydrogenase 2*2 knock-in mice show increased reactive oxygen species production in response to cisplatin treatment.
Kim J; Chen CH; Yang J; Mochly-Rosen D
J Biomed Sci; 2017 May; 24(1):33. PubMed ID: 28532411
[TBL] [Abstract][Full Text] [Related]
7. Aldehyde dehydrogenases and their role in carcinogenesis.
Lindahl R
Crit Rev Biochem Mol Biol; 1992; 27(4-5):283-335. PubMed ID: 1521460
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.
Prince MEP; Zhou L; Moyer JS; Tao H; Lu L; Owen J; Etigen M; Zheng F; Chang AE; Xia J; Wolf G; Wicha MS; Huang S; Ren X; Li Q
Oral Oncol; 2016 Aug; 59():30-42. PubMed ID: 27424180
[TBL] [Abstract][Full Text] [Related]
9. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
[TBL] [Abstract][Full Text] [Related]
10. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
Lim YC; Kang HJ; Moon JH
Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
[TBL] [Abstract][Full Text] [Related]
11. SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer.
Huang Z; Li H; Huang Q; Chen D; Han J; Wang L; Pan C; Chen W; House MG; Nephew KP; Guo Z
Mol Carcinog; 2014 Oct; 53(10):777-86. PubMed ID: 23661500
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
13. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents.
Dinavahi SS; Gowda R; Bazewicz CG; Battu MB; Lin JM; Chitren RJ; Pandey MK; Amin S; Robertson GP; Gowda K
Eur J Med Chem; 2020 Feb; 187():111962. PubMed ID: 31887569
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.
Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934
[TBL] [Abstract][Full Text] [Related]
16. Ectopic overexpression of CD133 in HNSCC makes it resistant to commonly used chemotherapeutics.
Lee J; Park M; Ko Y; Kim B; Kim O; Hyun H; Kim D; Sohn H; Moon YL; Lim W
Tumour Biol; 2017 Apr; 39(4):1010428317695534. PubMed ID: 28381190
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
Kurth I; Hein L; Mäbert K; Peitzsch C; Koi L; Cojoc M; Kunz-Schughart L; Baumann M; Dubrovska A
Oncotarget; 2015 Oct; 6(33):34494-509. PubMed ID: 26460734
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J
Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance.
Liu S; Ren B; Gao H; Liao S; Zhai YX; Li S; Su XJ; Jin P; Stroncek D; Xu Z; Zeng Q; Li Y
J Transl Med; 2017 Sep; 15(1):189. PubMed ID: 28877725
[TBL] [Abstract][Full Text] [Related]
20. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.
Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM
Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
